EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The impact of COVID ‐19 on people with epilepsy: Global results from the coronavirus and epilepsy study

Michael J Vasey iD, Xin You Tai, Jennifer Thorpe, Gabriel Davis Jones, Samantha Ashby, Asma Hallab, Ding Ding iD, Maria Andraus, Patricia Dugan iD, Piero Perucca iD, Daniel J Costello iD, Jacqueline A French iD und 16 weitere

Epilepsia Open · 2024

DOI: 10.1002/epi4.13035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsia Open, 2024. Verfasst von Michael J Vasey und 27 weiteren Autor:innen. Beteiligte Einrichtung: East London NHS Foundation Trust, Bedford, UK. Hauptthemen laut MEDLINE: COVID-19, Epilepsy, Health Personnel. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To characterize the experience of people with epilepsy and aligned healthcare workers (HCWs) during the first 18 months of the COVID‐19 pandemic and compare experiences in high‐income countries (HICs) with non‐HICs.

Methods

Separate surveys for people with epilepsy and HCWs were distributed online in April 2020. Responses were collected to September 2021. Data were collected for COVID‐19 infections, the effect of COVID‐related restrictions, access to specialist help for epilepsy (people with epilepsy), and the impact of the pandemic on work productivity (HCWs). The frequency of responses for non‐HICs and HICs were compared using non‐parametric Chi‐square tests.

Results

Two thousand one hundred and five individuals with epilepsy from 53 countries and 392 HCWs from 26 countries provided data. The same proportion of people with epilepsy in non‐HICs and HICs reported COVID‐19 infection (7%). Those in HICs were more likely to report that COVID‐19 measures had affected their health (32% vs. 23%; p < 0.001). There was no difference between non‐HICs and HICs in the proportion who reported difficulty in obtaining help for epilepsy. HCWs in non‐HICs were more likely to report COVID‐19 infection than those in HICs (18% vs 6%; p = 0.001) and that their clinical work had been affected by concerns about contracting COVID‐19, lack of personal protective equipment, and the impact of the pandemic on mental health (all p < 0.001). Compared to pre‐pandemic practices, there was a significant shift to remote consultations in both non‐HICs and HICs ( p < 0.001). Significance While the frequency of COVID‐19 infection was relatively low in these data from early in the pandemic, our findings suggest broader health consequences and an increased psychosocial burden, particularly among HCWs in non‐HICs. Planning for future pandemics should prioritize mental healthcare alongside ensuring access to essential epilepsy services and expanding and enhancing access to remote consultations. Plain Language Summary We asked people with epilepsy about the effects of COVID‐19 on their health and healthcare. We wanted to compare responses from people in high‐income countries and other countries. We found that people in high‐income countries and other countries had similar levels of difficulty in getting help for their epilepsy. People in high‐income countries were more likely to say that their general health had been affected. Healthcare workers in non‐high‐income settings were more likely to have contracted COVID‐19 and have the care they deliver affected by the pandemic. Across all settings, COVID‐19 associated with a large shift to remote consultations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19EpilepsyHealth PersonnelHumansFemaleMaleAdultMiddle AgedSurveys and QuestionnairesYoung AdultDeveloped CountriesSARS-CoV-2Health Services AccessibilityGlobal HealthAdolescent

Stichwörter der Autor:innen

access to healthcaremental healthpandemic responseseizuretelemedicine

Autor:innen und Institutionen

  • East London NHS Foundation Trust, Bedford, UK.
  • Nuffield Department of Clinical Neurosciences, Oxford Epilepsy Research Group, University of Oxford, Oxford, UK.
  • SUDEP Action, Wantage, UK.
  • Charité-Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Biologie Intégrative et Physiologie - Neurosciences Cellulaires et Intégrées, Faculté des Sciences et Ingénierie, Sorbonne Université, Paris, France.
  • Institute of Neurology, Fudan University Huashan Hospital, Shanghai, China.

ORCID-Profile: Michael J Vasey, Ding Ding, Patricia Dugan, Piero Perucca, Daniel J Costello, Jacqueline A French, Norman Delanty, Nathalie Jette, Martin J Brodie, Orrin Devinsky, J Helen Cross, Josemir W Sander, Arjune Sen

Zitieren

APA

Vasey, M. J., Tai, X. Y., Thorpe, J., Jones, G. D., Ashby, S., Hallab, A., Ding, D., Andraus, M., Dugan, P., Perucca, P., Costello, D. J., French, J. A., O'Brien, T. J., Depondt, C., Andrade, D. M., Sengupta, R., Datta, A., Delanty, N., Jette, N., …, & COVID‐19 Epilepsy COV‐E Study Group (2024). The impact of COVID ‐19 on people with epilepsy: Global results from the coronavirus and epilepsy study. Epilepsia Open. https://doi.org/10.1002/epi4.13035

Vancouver

Vasey MJ, Tai XY, Thorpe J, Jones GD, Ashby S, Hallab A, et al. The impact of COVID ‐19 on people with epilepsy: Global results from the coronavirus and epilepsy study. Epilepsia Open. 2024. doi:10.1002/epi4.13035

BibTeX
@article{Vasey2024,
  author = {Vasey, Michael J and Tai, Xin You and Thorpe, Jennifer and Jones, Gabriel Davis and Ashby, Samantha and Hallab, Asma and Ding, Ding and Andraus, Maria and Dugan, Patricia and Perucca, Piero and Costello, Daniel J and French, Jacqueline A and O'Brien, Terence J and Depondt, Chantal and Andrade, Danielle M and Sengupta, Robin and Datta, Ashis and Delanty, Norman and Jette, Nathalie and Newton, Charles R and Brodie, Martin J and Devinsky, Orrin and Cross, J Helen and Sander, Josemir W and Hanna, Jane and Besag, Frank M C and Sen, Arjune and COVID‐19 Epilepsy COV‐E Study Group, COVID‐19 Epilepsy COV‐E Study Group},
  title = {The impact of COVID ‐19 on people with epilepsy: Global results from the coronavirus and epilepsy study},
  journal = {Epilepsia Open},
  year = {2024},
  doi = {10.1002/epi4.13035}
}
Kostenlos starten →